Development of ADAMTS13 inhibitor in a patient with hepatitis C virus-related liver cirrhosis causes thrombotic thrombocytopenic purpura.
Yagita
Masato
M
Uemura
Masahito
M
Nakamura
Takefumi
T
Kunitomi
Akane
A
Matsumoto
Masanori
M
Fujimura
Yoshihiro
Y
D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; D000368:Aged; D001663:Bilirubin / Q000097:blood; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008103:Liver Cirrhosis / Q000821:virology*; D008297:Male; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors / Q000097:blood*; D010951:Plasma Exchange; D011697:Purpura, Thrombotic Thrombocytopenic / Q000097:blood* / Q000628:therapy; D012016:Reference Values; D016896:Treatment Outcome
D007770:L-Lactate Dehydrogenase; D051722:ADAM Proteins; D008666:Metalloendopeptidases; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human; D001663:Bilirubin